Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive Assessment of Cancer Theranostic Response; Investigating the Intent to Change Treatment Decisions Based on TRAQinform Theranostics

NCT06815354 is registered in ClinicalTrials.gov with AIQ Solutions as lead sponsor.

NCT NCT06815354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06815354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive Assessment of Cancer Theranostic Response; Investigating the Intent to Change Treatment Decisions Based on TRAQinform Theranostics
Lead sponsor
AIQ Solutions
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 2, 2024
Completion date
December 31, 2026
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer